In vivo SELEX for Identification of Brain-penetrating Aptamers.
about
Progress and perspectives on targeting nanoparticles for brain drug delivery.Generation of Aptamers with an Expanded Chemical RepertoireOpportunities in the design and application of RNA for gene expression controlIn vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugsBlocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersCell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyRNA based antagonist of NMDA receptorsCell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineQuantitative PCR analysis of DNA aptamer pharmacokinetics in mice.RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.Aptamer technology for tracking cells' status & function.Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity.Library-based display technologies: where do we stand?Cell-targeting aptamers act as intracellular delivery vehicles.Aptamers as theranostic agents: modifications, serum stability and functionalisationNADPH oxidase in brain injury and neurodegenerative disordersInhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.Small RNA drugs for prion disease: a new frontier.Aptamers: multifunctional molecules for biomedical research.Oligonucleotide aptamers: new tools for targeted cancer therapy.Aptamers as drug delivery vehicles.Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.Aptamers as targeted therapeutics: current potential and challenges.Trends in aptamer selection methods and applications.Status and Prospects of Aptamers as Drug Components.Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX.Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panning.The expanding world of DNA and RNA.Aptahistochemistry in diagnostic pathology: technical scrutiny and feasibility.Development of aptamers against unpurified proteins.A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect.Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.DNA-scaffolded multivalent ligands to modulate cell function.Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery.Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology.In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library.Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.
P2860
Q26740580-60CDBBF6-DB03-4B78-B0CA-E9783469B5D6Q26782794-6E9656E0-C1E7-4B49-B038-15278207B896Q28075458-349FD35B-A8C1-4069-9F08-FC63F19CFBFDQ28828886-6A43F080-CD65-4893-BBC1-0208E04C3F53Q33696539-C6EB6A7F-54D7-4EFE-ABD4-3364F2CA748BQ33832781-22C1DD95-4501-459E-A88D-CA6077CE0AAAQ33834772-F0EB4EFD-423A-4EED-B5DC-B2A720ECDD2AQ33918208-02F99CAF-0843-4B45-A2A8-CAF3DE543137Q34232003-CB8DEDEE-70E9-4307-88C8-EF0A594B8F50Q34459376-11C0486F-9767-4133-A8A3-4B57C9B79428Q34698624-3F8DB201-21F1-4E9E-96A4-C40443D760A6Q34976853-19280780-D0E6-4658-ADD6-D39C40EBB946Q35108312-7959AA40-0FF3-436A-98F0-B5B7C32CB4FAQ35673895-CD761A17-6DDB-4F8E-9AB0-8A363AEFBBEAQ35682065-6241FFBF-E006-4C0B-92A5-24AD56AEC95FQ36053596-D651216E-3CCF-4CD8-AF89-142F0B7DCFC7Q36062913-1338ECA2-4BC1-4469-8B7A-2F8EB177C8B6Q37383122-3FC824BA-A834-4EC4-89F5-BE6A422C5A88Q37589114-EBBCCFFC-3343-4B6F-AE58-AB9FF01D5BFCQ37696048-26414E2F-BCE0-4131-879B-F0A55858E5D8Q38121120-281642BB-CD76-45C0-929A-3C2191834469Q38138814-349B3D15-3070-410C-B98A-332005E30F56Q38237132-98AB6D51-DFBA-482E-BEB4-D15AC9F925A2Q38240594-DFD254DE-7428-4338-9B23-77D39689529EQ38288126-963EF5C5-0883-46FA-B21D-5279CB3A529FQ38290290-084D244F-C3AA-4C96-91CB-4E2BACBE99ABQ38298067-6DFAEABE-A221-4E25-A8D2-A65C9D8405CDQ38488502-4117A178-2412-40C3-88C7-DD70B799D6C5Q38609277-21D485A8-EA38-473F-80E3-108FEDF65113Q38773272-F0774D20-FD80-4CB7-B096-C986B12DD74AQ38938145-05BD36B5-8277-4A5D-9DFD-C4F2E5B26C0FQ39189144-EB2C7245-84C9-4CE5-BF44-7763E13E1F35Q39451666-EACA1695-B618-4EE8-949D-E2C63509C297Q41538262-1C79CBA0-D5AB-4E66-AD12-098948155771Q45265302-D04B9644-FC1F-4A89-899F-59787B5B442BQ46196202-4AB12257-2733-4CD9-8D08-EA34BCD11BF0Q47104247-37568769-7B6A-46A1-AFEC-02B566025797Q48313209-F90A6DBC-CE7C-4F58-A5AC-948779696C93Q49196378-C6FC7B13-CE12-4B27-9D05-E1CCD4427712Q50099625-A51AA29A-734E-444E-8892-BF3DF0A14054
P2860
In vivo SELEX for Identification of Brain-penetrating Aptamers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@ast
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@en
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@nl
type
label
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@ast
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@en
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@nl
prefLabel
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@ast
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@en
In vivo SELEX for Identification of Brain-penetrating Aptamers.
@nl
P2093
P2860
P356
P1476
In vivo SELEX for Identification of Brain-penetrating Aptamers
@en
P2093
Beverly L Davidson
Congsheng Cheng
Kim A Lennox
Yong Hong Chen
P2860
P356
10.1038/MTNA.2012.59
P577
2013-01-08T00:00:00Z